शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
INDOBORAXNSEINDO BORAX & CHEMICAL LTD· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 24 Sept, 2026 · 15:47 IST

Indo Borax raises about 225 crore for Kronox Lab Sciences acquisition

Listed-company acquisitionStrategic Transactions View source PDFExplain this filing

INDOBORAX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.2%Reaction day
₹450.25
prior close
₹455.80
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-0.1% vs market
Commodity Chemicals peers, median of 58sector+0.4%-0.3% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-0.5
15m
-0.1
30m
-0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.2+0.3-0.1+0.4-0.3
Next day
+7.1-1.3+8.4-0.9+7.9
2d
+8.5-0.3+8.8+0.1+8.4
3d
+6.1-0.6+6.7-0.8+6.9
4d
+4.2-1.8+6.0-0.6+4.8
5d
+2.2-1.8+4.0-1.8+3.9
1w
+6.6-0.8+7.4-1.0+7.6
15d
+1.7-4.1+5.9-2.6+4.3
1m
-10.4-9.4-1.0-7.7-2.7
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 58Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indo Borax and Chemicals has availed funding of about 225 crore from a lending institution on 23 September 2026 to finance its previously disclosed acquisition of equity shares of Kronox Lab Sciences Limited. The company will make further disclosures as required under SEBI Listing Regulations.

Likely market impact

Confirms progress on the Kronox Lab Sciences deal. Adds about 225 crore of debt; effect on earnings will depend on the acquired business performance.